XtalPi Acquires Liverpool ChiroChem (LCC)

XtalPi has acquired Liverpool ChiroChem (LCC), a specialist in automated chiral chemistry and high‑throughput chiral molecule synthesis, to integrate LCC’s PACE technology and chiral building‑block library into XtalPi’s AI- and robotics‑driven drug and materials R&D platform. The deal expands XtalPi’s end‑to‑end predictive and automated chemistry capabilities, accelerating discovery and synthesis of novel chiral compounds for pharmaceutical, materials, agricultural, and specialty chemical customers.